Connection

Istvan Takacs to Antibodies, Monoclonal

Back to Details
This is a "connection" page, showing publications Istvan Takacs has written about Antibodies, Monoclonal.
Istvan Takacs
Connection Strength
0.121
Antibodies, Monoclonal
  1. Avelumab, an anti-PD-L1 antibody, in patients with locally advanced or metastatic breast cancer: a phase 1b JAVELIN Solid Tumor study. Breast Cancer Res Treat. 2018 02; 167(3):671-686.
    View in: PubMed
    Score: 0.121
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.